CCA
CELG

Clearwater Capital Advisors’s Celgene Corp CELG Stock Holding History

Clearwater Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,565
Closed -$140K – 618
2018
Q1 		$140K Sell
1,565
-1,260
-45% -$121K 0.03% 206
2017
Q4 		$295K Buy
+2,825
New +$319K 0.06% 148

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clearwater Capital Advisors's CELG Position: Q2 2018 in Review

Clearwater Capital Advisors sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 1,565 shares — an estimated $140K sold.

Clearwater Capital Advisors first reported a position in CELG in Q4 2017 and held it in 2 quarters. The position peaked at $295K in Q4 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Clearwater Capital Advisors reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Clearwater Capital Advisors sold 1,565 Celgene Corp shares in Q2 2018, an estimated $140K.
  • Clearwater Capital Advisors first reported a position in Celgene Corp in Q4 2017 and held it in 2 quarters.
  • Clearwater Capital Advisors's Celgene Corp position peaked at $295K in Q4 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Clearwater Capital Advisors's 13F filing for Q2 2018, filed 16 Aug 2018.